BRIEF-Glaxosmithkline says presents new data on efficacy of Nucala
March 07, 2016 at 13:05 PM EST
* GSK presents data at AAAAI on efficacy of Nucala (Mepolizumab) in severe asthma patients stratified by Eosinophil levels
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.